Mild-To-Moderate Ulcerative Colitis

In this Healio video exclusive, Tara Muzsi, vice president of sales and marketing for gastroenterology at Janssen Pharmaceuticals, discusses the company’s Stelara UnstoppaBOLD 2.0 campaign for patients with inflammatory bowel disease.

In a real-world Crohn’s disease population, biologic- naive patients, compared with biologic-experienced patients, had a significantly greater chance for achieving mucosal healing, according to research at Digestive Disease Week.

Mucosal biofilms are endoscopic features in patients with irritable bowel syndrome and ulcerative colitis with disrupted bile acid metabolism and bacterial dysbiosis, according to a study in Gastroenterology.

Patients with cirrhosis had a higher abundance of beta-lactamase, vancomycin and quinolone genes in their gut microbiota compared with patients with inflammatory bowel disease, chronic kidney disease and diabetes, according to a presentation from Digestive Diseases Week.

Researchers from Cleveland Clinic found an infection that prevents healing in patients with Crohn’s disease, according to study results published in Science.

Childhood exposure to residential greenspace was associated with a reduced risk for inflammatory bowel disease, according to data published in the American Journal of Gastroenterology.

Researchers developed a wearable sweat senser device that may improve treatment of inflammatory bowel disease, according to a presenter at the virtual Crohn’s and Colitis Congress.

Complete remission at 8 weeks was observed in patients with steroid-resistant ulcerative colitis who received a high dose of adrenomedullin, according to study published in The Journal of Gastroenterology.